• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Patient-Reported Quality of Life in Patients with Neuroendocrine Tumors Following Surgical Resection.

作者信息

Rosowicz Andrew, Bangla Venu G, Divino Celia M

机构信息

Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Department of Surgery, General Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

Ann Surg Oncol. 2023 Oct;30(11):6786. doi: 10.1245/s10434-023-13787-8. Epub 2023 Jul 2.

DOI:10.1245/s10434-023-13787-8
PMID:37394669
Abstract
摘要

相似文献

1
ASO Author Reflections: Patient-Reported Quality of Life in Patients with Neuroendocrine Tumors Following Surgical Resection.ASO作者反思：手术切除后神经内分泌肿瘤患者的患者报告生活质量
Ann Surg Oncol. 2023 Oct;30(11):6786. doi: 10.1245/s10434-023-13787-8. Epub 2023 Jul 2.
2
ASO Author Reflections: Trends in the Number of Lymph Nodes Evaluated Following Resection of Pancreatic Neuroendocrine Tumors-An Increasing Adoption of the AJCC Guidelines?美国外科医师学会作者反思：胰腺神经内分泌肿瘤切除术后评估的淋巴结数量趋势——美国癌症联合委员会（AJCC）指南的采用率是否在上升？
Ann Surg Oncol. 2020 Apr;27(4):1213-1214. doi: 10.1245/s10434-019-08134-9. Epub 2019 Dec 12.
3
ASO Author Reflections: Can We Evaluate Surgical Quality for Pancreatic Neuroendocrine Tumors?美国外科医师学会作者反思：我们能否评估胰腺神经内分泌肿瘤的手术质量？
Ann Surg Oncol. 2024 Jun;31(6):4117-4118. doi: 10.1245/s10434-024-15209-9. Epub 2024 Apr 2.
4
ASO Author Reflections: Uninsurance is Associated with Worse Outcomes Following Resection for Gastro-Entero-Pancreatic Neuroendocrine Tumors.美国外科医师学会作者反思：未参保与胃肠胰神经内分泌肿瘤切除术后更差的预后相关。
Ann Surg Oncol. 2020 Sep;27(9):3154-3155. doi: 10.1245/s10434-020-08365-1. Epub 2020 Mar 18.
5
ASO Author Reflections: Reconsidering Resection for Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma.ASO作者反思：重新审视低分化胰腺神经内分泌癌患者的切除术
Ann Surg Oncol. 2022 Jun;29(6):3532-3533. doi: 10.1245/s10434-022-11479-3. Epub 2022 Feb 26.
6
ASO Author Reflections: Can Minimally Invasive Techniques Improve Quality of Life following Pancreatic Resection?《美国外科医师学会（ASO）作者反思：微创技术能否改善胰腺切除术后的生活质量？》
Ann Surg Oncol. 2019 Dec;26(Suppl 3):845-846. doi: 10.1245/s10434-019-07953-0. Epub 2019 Nov 26.
7
ASO Author Reflections: Refining the Surgical Management of Pancreatic Neuroendocrine Tumors.《美国外科医师学会杂志》作者反思：完善胰腺神经内分泌肿瘤的外科治疗
Ann Surg Oncol. 2021 Feb;28(2):1050-1051. doi: 10.1245/s10434-020-09169-z. Epub 2020 Sep 24.
8
ASO Author Reflections: Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors.ASO作者反思：淋巴结状态对胰腺神经内分泌肿瘤术前影像管理的准确性及预后影响
Ann Surg Oncol. 2024 May;31(5):2973-2974. doi: 10.1245/s10434-023-14827-z. Epub 2023 Dec 23.
9
ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B.ASO作者反思：将G2级胰腺神经内分泌肿瘤分为2A和2B亚级的预后价值
Ann Surg Oncol. 2024 Oct;31(10):7068-7069. doi: 10.1245/s10434-024-15728-5. Epub 2024 Jul 11.
10
ASO Author Reflections: Elevated Preoperative Specific Growth Rate is Associated with Shortened Survival After Resection for Pancreatic Neuroendocrine Tumors.ASO作者反思：术前特定生长率升高与胰腺神经内分泌肿瘤切除术后生存期缩短相关。
Ann Surg Oncol. 2020 Oct;27(10):3924-3925. doi: 10.1245/s10434-020-08527-1. Epub 2020 May 28.

本文引用的文献

1
Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection.类癌综合征对胃肠胰神经内分泌肿瘤患者手术切除的临床特征和结局的影响。
Surgery. 2019 Mar;165(3):657-663. doi: 10.1016/j.surg.2018.09.008. Epub 2018 Oct 28.
2
Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study.神经内分泌肿瘤诊断时类癌综合征的发生率：一项基于人群的研究。
Lancet Oncol. 2017 Apr;18(4):525-534. doi: 10.1016/S1470-2045(17)30110-9. Epub 2017 Feb 24.
3
Expanded criteria for carcinoid liver debulking: Maintaining survival and increasing the number of eligible patients.
类癌肝减瘤的扩展标准：维持生存率并增加符合条件的患者数量。
Surgery. 2014 Dec;156(6):1369-76; discussion 1376-7. doi: 10.1016/j.surg.2014.08.009. Epub 2014 Nov 11.
4
Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases.原发性中肠类癌肿瘤患者伴不可切除肝转移切除的系统回顾
Br J Surg. 2012 Nov;99(11):1480-6. doi: 10.1002/bjs.8842. Epub 2012 Sep 13.